Microbial contamination of clinical islet transplant preparations is associated with very low risk of infection

Diabetes Technology and Therapeutics

Volumn 15, Issue 4, 2013, Pages 323-327

  Gala Lopez, Boris ^a   Kin, Tatsuya ^a   O'gorman, Doug ^a   Pepper, Andrew R ^a   Senior, Peter ^a   Humar, Atul ^a   Shapiro, A M James ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; DACLIZUMAB; ETANERCEPT; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; CELL SURVIVAL; CLINICAL TRIAL; GOOD MANUFACTURING PRACTICE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MAJOR CLINICAL STUDY; MICROBIAL CONTAMINATION; MICROBIAL GROWTH; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STAPHYLOCOCCUS;

ADULT; ANTI-BACTERIAL AGENTS; DIABETES MELLITUS, TYPE 1; EQUIPMENT CONTAMINATION; FEMALE; GRAFT SURVIVAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; IMMUNOCOMPROMISED HOST; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PATIENT SELECTION; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84876137216     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0297     Document Type: Article

References (18)

1. Ryan EA, Bigam D, Shapiro AM: Current indications for pancreas or islet transplant. Diabetes Obes Metab 2006;8:1-7.
2. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems J, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DER, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FS, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JRT: International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318-1330.
3. Taylor G, Kirkland T, Lakey J, Rajotte R, Warnock G: Bacteremia due to transplantation of contaminated cryopreserved pancreatic islets. Cell Transplant 1994;3:103-106.
4. Bucher P, Oberholzer J, Bosco D, Mathe Z, Toso C, Bühler LH, Burney T, Morel P: Microbial surveillance during human pancreatic islet isolation. Transplant Int 2005;18:584-589.
5. Carroll PB, Ricordi C, Fontes P, Rilo HR, Phipps J, Tzakis AG, Fung JJ, Starzl TE: Microbiologic surveillance as part of human islet transplantation: Results of the first 26 patients. Transplant Proc 1992;24:2798-2799.
6. Lakey JR, Rajotte RV, Warnock GL: Microbial surveillance of human islet isolation, in vitro culture, and cryopreservation. Clin Invest Med 1995;18:168-176.
7. Scharp DW, Lacy PE, McLear M, Longwith J, Olack B: The bioburden of 590 consecutive human pancreata for islet transplant research. Transplant Proc 1992;24:974-975.
8. Kin T, Rosichuk S, Shapiro A, Lakey J: Detection of microbial contamination during human islet isolation. Cell Transplant 2006;15:1-100.
9. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW: Automated method for isolation of human pancreatic islets. Diabetes 1988;37:413-420.
10. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM: Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060-2069.
11. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM: Successful islet transplantation: Continued insulin reserve provides longterm glycemic control. Diabetes 2002;51:2148-2157.
12. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
13. O'Gorman D, Kin T, Imes S, Pawlick R, Senior P, Shapiro AM: Comparison of human islet isolation outcomes using a new mammalian tissue-free enzyme versus collagenase NB-1. Transplantation 2010;90:255-259.
14. Barbaro B, Salehi P, Wang Y, Qi M, Gangemi A, Kuechle J, Hansen MA, Romagnoli T, Avila J, Benedetti E, Mage R, Oberholzer J: Improved human pancreatic islet purification with the refined UIC-UB density gradient. Transplantation 2007;84:1200-1203.
15. Baidal DA, Froud T, Ferreira JV, Khan A, Alejandro R, Ricordi C: The bag method for islet cell infusion. Cell Transplant 2003;12:809-813.
16. Lloveras J, Farney AC, Sutherland DE, Wahoff D, Field J, Gores PF: Significance of contaminated islet preparations in clinical islet transplantation. Transplant Proc 1994;26:579-580.
17. Barshes NR, Wyllie S, Goss JA: Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: Implications for intrahepatic grafts. J Leukoc Biol 2005;77:587-597.
18. Gala-Lopez BL, Senior PA, Koh A, Kashkoush SM, Kawahara T, Kin T, Humar A, Shapiro AM: Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation. Am J Transplant 2011;11:2708-2714.